I
t is well acknowledged that the quality and quantity of host bone, presence of sufficient primary stability at the time of implant placement and formation of a direct bone-to-implant contact (BIC) are critical parameters that govern the overall success and survival of implants. [1] [2] [3] [4] However, implant surface characteristics (including surface topography, energy, chemistry, and roughness) also play significant roles in enhancing osseointegration and BIC. Studies have reported that increasing surface roughness of implants favors osteoblastic proliferation, collagen synthesis, and expression of integrins in the extracellular matrix, thereby improving the mechanisms associated with osseointegration. [5] [6] [7] [8] [9] [10] [11] [12] In this regard, some studies placed localized organic and inorganic osteogenic coatings on implant surfaces in an attempt to improve implant surface activity and osteopromotive activity. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Osteoporosis is a metabolic disease of bone characterized by low bone mineral density (BMD) and reduced bone mass due to impaired bone metabolism and imbalanced osteoblastic and osteoclastic activities. 24, 25 In osteoporotic bone, osteoblasts demonstrate impaired proliferative, synthetic, and reactive ability to cellular mediators. 24, 26, 27 Underlying causes of osteoporosis include premenopausal and postmenopausal estrogen deficiency, excessive glucocorticoid intake, eating disorders such as anorexia nervosa and celiac disease. 28, 29 Although the bone quality and strength are compromised in osteoporotic patients (compared with healthy individuals) because of low BMD and Purpose: The aim was to assess the significance of osteogenic surface coatings on implants to enhance osseointegration under osteoporoticlike (OP-like) conditions.
Methods: To address the focused question "Do osteogenic surface coatings on implants enhance osseointegration under OP-like conditions?" PubMed/MEDLINE and Google-Scholar databases were searched from 1995 up to and including February 2014 using various keywords. Unpublished data, letters to the editor, review articles, and articles published in languages other than English were excluded.
Results: Of the 28 studies identified, 11 experimental studies were included. These studies were performed on bilaterally ovariectomized animals. In all studies, implant surface roughness was increased by various osteogenetic surface coatings including alumina, hydroxyapatite, calcium phosphate, and zoledronic acid. Nine studies reported that compared with noncoated surfaces, osteogenic coatings on implant surfaces increases bone volume and bone-to-implant contact (BIC) under OP-like conditions. In 2 studies, there was no difference in BIC around hydroxyapatite-coated implants placed in animals with and without OP-like conditions.
Conclusion: Osteogenic coatings on implant surfaces enhanced osseointegration in animals with OP-like conditions. However, additional clinical studies are warranted to assess the role of osteogenic coatings in increasing osseointegration in patients with osteoporosis. (Implant Dent 2014;23:679-686) Key Words: bone-to-implant contact, coating, implant surface, osseointegration and osteoporosis osteoregenerative capacity of osteoporotic bone, osteoporosis is not considered a contraindication for implant placement. 30, 31 Because optimal bone volume (BV) and BIC are critical in establishing implant stability in bones with low BMD, and that implant surface topography influences the mechanisms of osseointegration, it is hypothesized that implant surfaces with osteogenic coatings increase osteoblastic activity thereby enhancing BV and BIC under osteoporotic-like (OP-like) conditions as compared with implants with noncoated surfaces. 13, 14, 32, 33 The aim of this study was to review the significance of osteogenic coatings on implant surfaces in enhancing osseointegration under OP-like conditions.
MATERIALS AND METHODS

Focused Question
The addressed focused question was "Do osteogenic coatings around implant surfaces enhance osseointegration under OP-like conditions?"
Eligibility Criteria
The following eligibility criteria were entailed: (1) original studies; (2) clinical and experimental studies; (3) intervention: role of modifications in Titanium (Ti) implant surfaces in enhancing osseointegration in OP-like conditions; (4) articles published only in English language. Letters to the Editor, commentaries, case reports, review articles, and unpublished articles were excluded.
Search Strategy
To address the focused question, PubMed/MEDLINE (National Library of Medicine, Bethesda, MD) and GoogleScholar databases were searched from 1995 up to and including February 2014 using different combinations of the following key words: "bone," "implant surface," "osseointegration," "osteoporosis," and "ovariectomy" (Fig. 1 ). Titles and abstracts of studies that fulfilled the eligibility criteria were screened by the authors and checked for agreement. Full texts of studies judged by title and abstract to be relevant were read and independently assessed against the selection protocol. After this, reference lists of original and review studies that were found to be pertinent in the previous step were handsearched and checked for agreement through discussion among the authors.
The initial search yielded 28 studies. Seventeen studies, which did not fulfill our eligibility criteria, were excluded (Appendix A). In total, 11 studies were included and processed for data extraction.
RESULTS
General Characteristics of the Studies
The general characteristics of the studies that were included in the present systematic review are summarized in Table 1 . All studies were experimental and were performed at University settings. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Rats, rabbits, and sheep were used in 5, 4, and 2 studies, respectively. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In these studies, the mean ages of rats, rabbits, and sheep ranged between 3 to 10 months, 6 to 15 months, and 2 to 7, years, respectively. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In all studies, the animals underwent bilateral ovariectomy (OVX) for the induction of OP-like conditions (Table 2) . [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] The follow-up period after implant placement ranged between 1 and 16 weeks. In studies by Fini et al 19 and Mardas et al, 20 implants were placed in the Fig. 1 . A schematic presentation of the literature search strategy used in this study. PubMed/ MEDLINE and Google-Scholar databases were searched from 1995 up to and including February 2014 using various key words. Letters to the editor, reviews, case reports, unpublished studies, and articles published in languages other than English were excluded. Disagreements among the authors regarding study selection were resolved through discussion. parietal bone and lumbar vertebrae, respectively. In the remaining studies, implants were either placed in the femoral condyle or tibia (Table 2) .
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Implant-Related Characteristics of the Studies Table 3 summarizes the implantrelated characteristics of the studies that fulfilled our eligibility criteria. In these studies, the numbers of implants placed ranged between 48 and 144. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In 6 studies, cylindrical implants were used. 13, 14, 17, 19, 22, 23 Screw-shaped implants were used in 4 studies. 15, 16, 18, 20 The lengths and diameters of implants used ranged between 3 to 30 mm and 2 to 5 mm, respectively. In 9 studies, osteogenic coatings were placed on Ti implants. [13] [14] [15] [16] [20] [21] [22] [23] In one study, stainless steel screws were coated with osteogenic materials. 19 In all studies, rough-surfaced dental implants were used. In the study by De Benedittis et al, 18 implants composed of different materials (including Ti, hydroxyapatite [HA] , and zirconia) were used. In 2 studies, calcium phosphate (CaP)-coated implants were used. 13, 14 Zoledronic acid (ZOL)-coated implant surfaces were used in 2 studies. 16, 22 Three studies assessed the effect of implants with and without a duplex coating of HA on osseointegration under OP-like conditions. 19, 21, 23 Jung et al 17 compared the efficacy of alumina-coated and HA-coated implants with machined surfaces in achieving osseointegration under OP-like conditions. In a study on rat models, efficacy of fibroblast growth factor with and without adjunct ZOL coating in increasing BV and BIC was assessed. 22 In one study, Ti implants were dipped in 2 different concentrations of a hypolipidemic drug before insertion in rat tibia. 15 
Main Outcome of Studies
Outcomes of all studies were based on histomorphometric analyses and/or microcomputotomographic assessment of region of interest (ie, bone-implant interface at the test and control sites). [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In 9 studies, BV and BIC were significantly higher around coated implants as compared with non-coated implants placed in subjects with OP-like conditions. [13] [14] [15] [16] [17] [18] [19] [20] 22 In 2 studies, there was no significant difference in BIC around HA-coated and non-coated implants placed in subjects with OP-like conditions. 21, 23 
DISCUSSION
From the literature reviewed, nearly 80% of studies reported that osteogenic coatings around implant surfaces enhance bone formation, BIC, and BV under OP-like conditions. This could possibly be accredited to the increase in surface roughness of the implant caused by osteogenic coatings, which facilitate the attachment of osteoprogenitor cells to the implant surface. Studies have also reported that implant surface roughness is directly associated with the degree of primary stability achieved and long-term success rate of the implant. 4, 34, 35 Based on these results, it is tempting to presume that rough-surfaced implants promote bone formation around implants in systemically healthy subjects and osteoporotic patients. However, it is pertinent to mention that all results included in the present review were derived from studies based on animal models. In these studies, OP-like conditions were established within 4 weeks to 24 months of OVX. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] From a clinical perspective, it is known that advancing age is a significant risk factor of osteoporosis. 36 Therefore, it may be questioned whether OP-like conditions induced in the experimental studies included in the present review truly replicate a clinical scenario of osteoporosis. In addition, hyperglycemia is a common manifestation in elderly patients with osteoporosis. 37 It is known that chronic hyperglycemia and aging undermine the differentiation and growth of osteoprogenitor cells. 38, 39 Therefore, it is hypothesized that merely using implants with osteogenic coatings in osteoporotic patients is unable to significantly enhance new bone formation. We support the experimental results by Borsari et al 23 in which HA-coated implants placed in aged sheep (with and without OVX) demonstrated no significant difference in their affinity indexes.
It is noteworthy that the choice of coating materials varied among the included studies. For example, results by Alghamdi et al 13, 14 showed that coating implant surfaces with CaP is effective in enhancing BIC and BV around implants compared with non-coated implants. An explanation in this regard may be that coating implants with CaP increases the attachment of osteoblastlike cells and mesenchymal stem cells on implant surfaces, and adsorption of proteoglycans that in turn promote osteogenic cell migration toward the implant surface. 40, 41 Likewise, 2 studies reported that ZOL-coated implants exhibit superior osseointegration under OP-like conditions compared with noncoated implants. 16, 22 It has been proposed that under OP-like conditions, ZOL coatings improve osseointegration of HA-coated implants by converting the rod-like structure of trabeculae (after estrogen deficiency) to the platelike structure thereby increasing bone mass around implants and improving implant fixation. 22 However, it has also been reported that coating implant surfaces with growth factors + ZOL gives the highest BIC than when ZOL is used alone. 22 In this regard, we find it exigent to elect a single implant coating material that would be most suitable for increasing osseointegration under OPlike conditions.
Results from a recent experimental study showed that the secondary stability of implants is associated with the BIC, and the role of implant diameter in this context is insignificant. 42 From the literature reviewed, we observed that implants used in the respective studies varied in diameters; however, histologic outcomes of most studies revealed significantly more BIC around coated implants compared with non-coated surfaces in animals with and without OP-like conditions. In general, outcomes of studies included in the present review are in accordance with those reported by Veltri et al. 42 
CONCLUSION
On experimental grounds, osteogenic surface coatings on implants enhanced osseointegration under OP-like conditions; however, additional long-term prospective clinical trials are warranted to assess the role of osteogenic coatings in increasing osseointegration in humans with osteoporosis.
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